Nyere principper og muligheder inden for astmabehandling
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Nyere principper og muligheder inden for astmabehandling. / Janner, Julie H; Ulrik, Charlotte Suppli.
In: Ugeskrift for Laeger, Vol. 169, No. 11, 2007, p. 995-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nyere principper og muligheder inden for astmabehandling
AU - Janner, Julie H
AU - Ulrik, Charlotte Suppli
PY - 2007
Y1 - 2007
N2 - In the coming years, asthma therapy should be tailored to the individual patient's needs. The principles of optimal asthma control and symptom-driven therapy offer the possibility for more individualised asthma management. Omalizumab (monoclonal anti IgE) may have positive clinical effects, including a reduction in the exacerbation-rate, and is indicated for patients, who--in spite of best possible asthma therapy--continue to have reduced lung function, severe exacerbations, severe symptoms, and documented non-seasonal allergy.
AB - In the coming years, asthma therapy should be tailored to the individual patient's needs. The principles of optimal asthma control and symptom-driven therapy offer the possibility for more individualised asthma management. Omalizumab (monoclonal anti IgE) may have positive clinical effects, including a reduction in the exacerbation-rate, and is indicated for patients, who--in spite of best possible asthma therapy--continue to have reduced lung function, severe exacerbations, severe symptoms, and documented non-seasonal allergy.
M3 - Tidsskriftartikel
VL - 169
SP - 995
EP - 997
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 11
ER -
ID: 48598088